# A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder

> **NCT01977378** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Jiangsu Hansoh Pharmaceutical Co., Ltd.** · enrollment: 300 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Sustained-Release Desvenlafaxine Hydrochloride
- **DRUG:** Sustained-Release Venlafaxine Hydrochloride

## Key facts

- **NCT ID:** NCT01977378
- **Lead sponsor:** Jiangsu Hansoh Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2014-09
- **Final completion:** —
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01977378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01977378, "A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01977378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*